# GABAPENTIN
> **ANDA207057** · Abbreviated New Drug Application (Generic) · Sponsor: CSPC OUYI · Approved 2017-10-26
## Drug
- **FDA Application Number:** ANDA207057
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GABAPENTIN
- **Generic name:** GABAPENTIN
- **Active ingredients:** GABAPENTIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CSPC OUYI
- **Manufacturer:** Precision Dose, Inc.
- **First approval:** 2017-10-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207057)
---
*AI Analytics · CC0 1.0*